Celldex 制药 CLDX
$29.87 +$1.60 (+5.66%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $30.00 +0.44%
开盘$27.85
昨收$28.27
当日区间$27.82 – $30.15
成交量926.3K
市值$2.35B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数10
平均目标价$69.80+133.7% 较现价
- 买入 100%
最低 $53.00现价 $29.87均值 $69.80最高 $100.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$50.00至$100.00，平均为$65.10。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 20 Oct 2026 | Morgan Stanley | BUY | $57.00 |
| 15 Oct 2026 | Wells Fargo | BUY | $72.00 |
| 13 Oct 2026 | Cantor Fitzgerald | BUY | $72.00 |
| 5 Oct 2026 | H.C. Wainwright | BUY | $64.00 |
| 3 Oct 2026 | LifeSci Capital | BUY | $64.00 |
| 2 Oct 2026 | H.C. Wainwright | BUY | $64.00 |
| 28 Sep 2026 | LifeSci Capital | BUY | $64.00 |
| 26 Sep 2026 | LifeSci Capital | BUY | $56.00 |
| 23 Sep 2026 | CCORF | BUY | $60.00 |
| 23 Sep 2026 | Wells Fargo | BUY | $72.00 |
| 23 Sep 2026 | Morgan Stanley | BUY | $57.00 |
| 23 Sep 2026 | Leerink Partners | BUY | $88.00 |
| 23 Sep 2026 | H.C. Wainwright | BUY | $64.00 |
| 22 Sep 2026 | Morgan Stanley | BUY | $57.00 |
| 22 Sep 2026 | Stifel | BUY | $68.00 |
| 22 Sep 2026 | Guggenheim | BUY | $100.00 |
| 22 Sep 2026 | H.C. Wainwright | BUY | $64.00 |
| 22 Sep 2026 | Barclays | BUY | $53.00 |
| 20 Sep 2026 | LifeSci Capital | BUY | $56.00 |
| 10 Sep 2026 | Morgan Stanley | BUY | $50.00 |
暂无评论——快来第一个聊聊 CLDX。